Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 9c

August 1, 2019 5:52 PM

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29).“We have had a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found